Kovack Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,359
Closed -$240K 1037
2025
Q4
$240K Buy
+2,359
New +$189K 0.01% 865
2023
Q3
Sell
-2,434
Closed -$229K 567
2023
Q2
$229K Buy
+2,434
New +$190K 0.03% 480
2021
Q4
Sell
-2,635
Closed -$252K 727
2021
Q3
$252K Hold
2,635
0.03% 586
2021
Q2
$328K Buy
2,635
+100
+4% +$11.9K 0.04% 478
2021
Q1
$334K Hold
2,535
0.04% 418
2020
Q4
$336K Sell
2,535
-100
-4% -$12.1K 0.05% 371
2020
Q3
$269K Hold
2,635
0.05% 353
2020
Q2
$229K Buy
+2,635
New +$211K 0.04% 371
2020
Q1
Sell
-2,635
Closed -$244K 497
2019
Q4
$244K Buy
2,635
+150
+6% +$13.2K 0.04% 409
2019
Q3
$225K Buy
2,485
+235
+10% +$26.8K 0.05% 397
2019
Q2
$266K Sell
2,250
-950
-30% -$95.7K 0.06% 331
2019
Q1
$277K Hold
3,200
0.07% 309
2018
Q4
$202K Hold
3,200
0.06% 347
2018
Q3
$253K Buy
+3,200
New +$209K 0.07% 333
2018
Q2
Sell
-10,896
Closed -$439K 458
2018
Q1
$439K Buy
10,896
+61
+0.6% +$2.98K 0.11% 218
2017
Q4
$569K Buy
10,835
+1,185
+12% +$63.3K 0.14% 173
2017
Q3
$455K Sell
9,650
-125
-1% -$5.03K 0.15% 162
2017
Q2
$346K Buy
+9,775
New +$302K 0.11% 216

Other funds holding EXAS

Kovack Advisors's EXAS Position: Q1 2026 in Review

Kovack Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,359 shares — an estimated $240K sold.

Kovack Advisors first reported a position in EXAS in Q2 2017 and held it in 18 quarters. The position peaked at $569K in Q4 2017. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Kovack Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Kovack Advisors sold 2,359 Exact Sciences shares in Q1 2026, an estimated $240K.
  • Kovack Advisors first reported a position in Exact Sciences in Q2 2017 and held it in 18 quarters.
  • Kovack Advisors's Exact Sciences position peaked at $569K in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.